Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

Indian Clinical Trial Market to show Double Digit Growth

Dec 03, 2010
Share |
 
India has registered fast growth in the number of clinical trials during the past few years, reflecting that the country has become one of the most attractive destinations for medical research. It is expected that the Indian market will outpace the growth of other clinical trials market in future. According to our research report Booming Clinical Trials Market in India, India’s clinical trial market is anticipated to grow at a CAGR of around 29% during 2009-2013. Our report has analyzed the drivers that are driving this growth.
 
Pharmaceutical companies have been finding ways to reduce cost and maintain a growth momentum and for this they are relying on outsourcing. According to a survey, India is considered as the best destination for pharma outsourcing followed by Korea and Taiwan. One of the major opportunities created by the clinical trial market is in the field of pathology and In vitro Diagnostics (IVD). The emerging market trends in Indian clinical trial market have been analyzed in our report. Forecast for these trends have been also covered in our report.
 
Growth of the clinical trials market is likely to open many opportunities in the country. With the growth of the clinical trials market, many associated sectors like IVD market and education sector are also likely to pick pace. The market is also expected to create job opportunities for clinical research professionals in future. But there are many challenges looming over the industry; ethical issues comprise the biggest challenge as many unethical clinical trials had been conducted in the past.
 
We have included certain steps that need to be addressed to ensure proper growth of the Indian clinical trial industry. The report has conducted a detailed cost analysis for all the four phases of clinical trials. Moreover, the report discusses the regulatory environment along with infrastructure and expertise. In addition, our report provides information on key players along with their strengths and weaknesses.

For more information visit: http://www.rncos.com/Report/IM564.htm

Related Press Releases:
» US Generic Drugs to Grow Strongly in Future
» FDI Fuelling Growth of Hospital Services in India
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports